OpenAI Data Center Chief Chris Malone Exits Ahead of Planned 2027 Listing 
China EV Stocks Slide as Door Handle Recall Hits 4.3 Million Vehicles 
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan 
J.P. Morgan Upgrades Diploma, Lifts Price Target to 8,250p 
Nvidia Options Price in $280 Billion Earnings Swing 
Adidas, Puma Shares Fall as Dick’s Sporting Goods Cuts Outlook 
Yindjibarndi Appeals Fortescue Mining Compensation Ruling 
Bathla Group Hires Administrators as Australia Housing Slump Deepens 
HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook 
Xiaomi Unveils Xring O3 Chip for Flagship Foldable Phone 
Google Expands Gemini Enterprise With AI Tools for Legal Sector 
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation 
SK Hynix Shares Fall as Workers Reject Wage Deal 
Australia’s Big Four Banks Face Mortgage Slowdown as Valuations Draw Scrutiny 
Trump Buys SpaceX Shares After Record IPO 
Add as a preferred source on Google
BUENA, N.J., April 26, 2018 -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30pm ET on Monday, May 7, 2018 to discuss the 1st quarter 2018 financial results and business update.
The Company invites you to listen to the call by dialing (866) 393-8366. International participants should call (409) 350-3154. Participants should ask to join the Teligent, Inc. call.
This call is available via webcast and can be accessed in the Investor Relations Section of Teligent, Inc.'s website at www.teligent.com.
About Teligent, Inc.
Teligent is a specialty generic pharmaceutical company. Our mission is to be a leading player in the specialty generic prescription drug market. Learn more on our website www.teligent.com.
Contact:
Damian Finio
Teligent, Inc.
(856) 336-9117
www.teligent.com
